2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

José A. Joglar, Mina K. Chung, Anastasia L. Armbruster, Emelia J. Benjamin, Janice Y. Chyou, Edmond M. Cronin, Anita Deswal, Lee L. Eckhardt, Zachary D. Goldberger, Rakesh Gopinathannair, Bulent Gorenek, Paul L. Hess, Mark Hlatky, Gail Hogan, Chinwe Ibeh, Julia H. Indik, Kazuhiko Kido, Fred Kusumoto, Mark S. Link, Kathleen T. LintaGregory M. Marcus, Patrick M. McCarthy, Nimesh Patel, Kristen K. Patton, Marco V. Perez, Jonathan P. Piccini, Andrea M. Russo, Prashanthan Sanders, Megan M. Streur, Kevin L. Thomas, Sabrina Times, James E. Tisdale, Anne Marie Valente, David R. Van Wagoner

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)E1-E156
JournalCirculation
Volume149
Issue number1
DOIs
StatePublished - Jan 2 2024

ASJC Scopus Subject Areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Keywords

  • acute coronary syndrome
  • AHA Scientific Statements
  • alcohol
  • anticoagulants
  • anticoagulation agents
  • antiplatelet agents
  • apixaban
  • atrial fibrillation
  • atrial flutter
  • cardioversion
  • catheter ablation
  • coronary artery disease
  • coronary heart disease
  • dabigatran
  • edoxaban
  • exercise
  • heart failure
  • hypertension
  • idarucizumab
  • left atrial appendage occlusion
  • myocardial infarction
  • obesity
  • percutaneous coronary intervention
  • pulmonary vein isolation
  • risk factors
  • rivaroxaban
  • sleep apnea
  • stents
  • stroke
  • surgical ablation
  • thromboembolism
  • warfarin

Cite this